PTC Therapeutics, Inc.

NasdaqGS:PTCT Stock Report

Market Cap: US$3.3b

PTC Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:PTCT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Jul 24SellUS$77,200Pierre GravierIndividual2,269US$34.02
07 May 24SellUS$5,744Lee GoldenIndividual175US$32.82
19 Apr 24SellUS$83,669Matthew KleinIndividual3,361US$24.89
17 Apr 24SellUS$32,851Matthew KleinIndividual1,307US$25.14
17 Apr 24SellUS$19,781Eric PauwelsIndividual787US$25.14
02 Apr 24SellUS$14,923Lee GoldenIndividual526US$28.37
30 Jan 24SellUS$8,666Christine UtterIndividual318US$27.25
30 Jan 24SellUS$9,974Eric PauwelsIndividual366US$27.25
30 Jan 24SellUS$17,604Neil AlmsteadIndividual646US$27.25
30 Jan 24SellUS$21,637Mark BouldingIndividual794US$27.25
09 Jan 24SellUS$83,950Neil AlmsteadIndividual2,910US$29.01
09 Jan 24SellUS$81,986Christine UtterIndividual2,841US$29.01
09 Jan 24SellUS$57,739Lee GoldenIndividual2,000US$29.01
09 Jan 24SellUS$221,996Matthew KleinIndividual7,680US$29.01
09 Jan 24SellUS$97,960Mark BouldingIndividual3,395US$29.01
09 Jan 24SellUS$104,852Eric PauwelsIndividual3,634US$29.01
05 Jan 24SellUS$274,393Matthew KleinIndividual10,107US$27.15
12 Dec 23BuyUS$198,736Pierre GravierIndividual7,700US$25.81

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PTCT?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,786,0692.19%
Hedge Funds14,628,02517.9%
Institutions65,183,58979.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.2%.

Top Shareholders

Top 25 shareholders own 86.97% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.8%
The Vanguard Group, Inc.
9,125,134US$394.5m1.69%0.01%
10.4%
BlackRock, Inc.
7,983,213US$345.1m2.72%0.01%
10.2%
Wellington Management Group LLP
7,892,799US$341.2m-3.85%0.05%
9.59%
RTW Investments, LP
7,393,127US$319.6m0%4.37%
9.38%
Armistice Capital LLC
7,234,898US$312.8m3.92%7.91%
4.66%
Cowen Inc,Private Banking and Investment Banking Investments
3,590,655US$155.2m-4.41%4.28%
4.54%
Camber Capital Management LP
3,500,000US$151.3m0%6.19%
3.76%
State Street Global Advisors, Inc.
2,899,040US$125.3m5.44%no data
2.42%
Janus Henderson Group plc
1,870,217US$80.8m-37.3%0.03%
2.33%
Geode Capital Management, LLC
1,798,666US$77.8m0.61%0.01%
1.95%
Michael Schmertzler
1,501,860US$64.9m0%no data
1.93%
Jacobs Levy Equity Management Inc
1,486,297US$64.3m-13.4%0.23%
1.84%
D. E. Shaw & Co., L.P.
1,419,539US$61.4m4.56%0.08%
1.79%
Franklin Resources, Inc.
1,378,483US$59.6m-2.16%0.02%
1.42%
Morgan Stanley, Investment Banking and Brokerage Investments
1,094,596US$47.3m-25.1%0.01%
1.37%
FMR LLC
1,057,068US$45.7m-4.26%no data
1.04%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
804,156US$34.8m17.8%0.01%
0.92%
Charles Schwab Investment Management, Inc.
706,730US$30.6m7.27%no data
0.91%
Tang Capital Management, LLC
700,000US$30.3m0%2.24%
0.88%
Northern Trust Global Investments
675,262US$29.2m2.55%no data
0.86%
Voloridge Investment Management, LLC
660,532US$28.6m-15.7%0.1%
0.84%
Point72 Asset Management, L.P.
647,936US$28.0m12.1%0.07%
0.73%
T. Rowe Price Group, Inc.
559,746US$24.2m-7.74%no data
0.71%
Blackstone Inc.
547,645US$23.7m0%0.09%
0.71%
Blackstone Life Sciences
547,645US$23.7m0%25.15%